An initiative of IBA Proton Therapy
Campus your proton
therapy community
  • Resource center
  • Training
  • Events
  • About
  • Log in
  • Resource center
  • Training
  • Events
  • About
  • Log in
An initiative of IBA Proton Therapy

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event - Do not use (0)
  • Podcast (0)
  • Publications (235)
  • Training (0)
  • User case (4)
  • User meeting (1)
  • Webinar (13)
  • White paper (2)
Key content topics
Key audience
  • Newcomers (0)
Top cancer treatments
  • Brain and CNS (88)
  • Breast (59)
  • (-) Gastro-intestinal (125)
  • Genito-urinary (51)
  • Gynecological (7)
  • (-) Head and neck (133)
  • Hodgkin and Non-Hodgkin lymphoma (16)
  • Ocular (12)
  • Pediatric (100)
  • Reirradiation (12)
  • Sarcomas (18)
  • Thoracic (91)
  • Reset filters
  • (-) Gastro-intestinal
  • (-) Head and neck

Comparative toxicity outcomes of PBT vs IMRT for prostate cancer in the postoperative setting.

07/09/2019
/ Publications
/
Toxicity

A case-matched cohort analysis study compared acute and late genitourinary (GU) and gastrointestinal (GI) toxicity outcomes in patients with prostate cancer (PC...

A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiotherapy for Esophageal Cancer.

07/07/2019
/ Publications
/
Quality of life

This study by Mayo Clinic aimed to compare Functional Assessment of Cancer Therapy - Esophagus (FACT-E) questionnaire changes during proton (PRT) or photon (XRT...

Clinical Results of Proton Beam Therapy for Esophageal Cancer

07/07/2019
/ Publications

A large retrospective study of 202 patients (90 inoperable patients and 100 patients (49.5%) had stage III/IV cancer) who were treated with PBT in Japan. This...

Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer.

03/04/2019
/ Publications
/
Chemotherapy

A study by the Tsukuba group in Japan repored outcomes of 42 unresectable locally advanced pancreatic cancer patients treated with PBT and concurrent...

Proton Radiotherapy for Isolated Local Recurrence of Primary Resected Pancreatic Ductal Adenocarcinoma.

03/05/2019
/ Publications

This study by the Hyogo group in Japan analyzed 30 patients who had initially undergone surgery but isolated local recurrence occurred. PBT was administered...

Early and late side effects, dosimetric parameters and QoL after PBT and IMRT for prostate cancer

03/03/2019
/ Publications
/
Dosimetry

A study by the researchers of Dresden and Heidelberg. Eighty-eight patients with localized prostate cancer treated with PBT (31) or IMRT (57) were matched using...

Patient-Reported Sexual Survivorship Following High-Dose Image-Guided PT for Prostate Cancer.

03/02/2019
/ Publications
/
Imaging System

A study by the Jacksonville group published in the Green Journal aimed to identify baseline predictive factors that impact long-term erectile function. 676...

Four-year outcomes from a prospective phase II clinical trial of moderately hypofractionated PT for localized prostate cancer.

04/06/2019
/ Publications

Published in the Red Journal, the researchers of Upenn and Groningen reported the clinical and patient-reported outcomes for patients with prostate cancer...

PBT outcomes for localized unresectable hepatocellular carcinoma.

03/01/2019
/ Publications
/
Survival
Toxicity

A MD Anderson study published in the Green Journal reported outcomes of forty-six patients with HCC, Child-Pugh class of A or B, no prior radiotherapy treated...

Consensus Report From the Miami Liver PT Conference.

03/05/2019
/ Publications

This paper is based on the Liver Focus Group supported by IBA. An International group of 22 liver cancer experts from 18 institutions were brought together in...

Pagination

  • Previous page ‹
    • Page 18
    • Current page 19
    • Page 20
  • Next page ›
Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
  • About Campus
  • Resources
  • Training
  • Connect
  • IBA Worldwide
  • Back to IBA Proton Therapy
Life Science
  • Legal
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies